Menu Content/Inhalt
News arrow Invited Lectures
Invited Lectures

Invited lectures of Dr. Podesser: 
 
Minimal-invasive surgery in 2012
Verona/Italy PhD lecture 6/2012
 
Which surgery in functional tricuspid regurgitation
Edwards Life Science Training Center Nyon/Switzerland 11/2011
 
Valve surgery- where are we going?
Edwards Life Science Training Center Nyon/Switzerland 11/2011
 
Heart valve treatment- a question of patient profiles and the surgeon’s choice
Herzzentrum Essen/Deutschland 4/2011
 
Principles of Mitral Valve surgery: the key question: replacement or reconstruction?
Medanta Medicenter New Dehli/India 7/2011
 
Principles of aortic root reconstruction.
MIOT Hospital and University, Chennai/India 7/2011
 
Tricuspid valve repair.
Narayana Hrudayalaya Hospital, Bangalore/India 7/2011
 
Valve replacement in mitral position-what are the real risks of biological and mechanical prostheses
University College Hospital Galway/Ireland 6/2010
 
Valve replacement in mitral position-what are the real risks of biological and mechanical prostheses
Royal Victoria Hospital, Belfast/UK 6/2010
 
Valve replacement in mitral position-what are the real risks
Medizinische Hochschule Hannover 6/2010
 
Minimal-invasive Vorgehen in der Herzklappenchirurgie
St. Pöltener Intensivtage 10/2010
 
Outcome in patients with small aortic annulus: 30d and long-term survival
Edwards Life Science Training Center Nyon/Switzerland 11/2010
 
Rational of cardioplegia and current practice in the old patient
Verona/Italy PhD lecture 6/2010
 
Replacement versus reconstruction in the old and multimorbid patient.
4th Joint Meeting of the Austrian, German and Swiss Societies of Cardiothoracic Surgery and Cardiology; Weissensee, 1/2010
 
Myocardial protection: new concepts and developments
Cuore Colloquio, University of Verona 3/2010
 
Myocardial protection: new concepts and developments
University of Debrecen/Hungary 4/2010
 
Direct NO donors in cardioplegia.
Italian Society for cardiothoracic Surgery, Annaul Meeting Tragliata/Italy 10/2009
 
Rational for cardioplegia and current practice in adult cardiac surgery.
Italian Society for cardiothoracic Surgery, Annaul Meeting Tragliata/Italy 10/2009
 
Mitral valve replacement: which valve for which patient.
Verona/Italy PhD lecture 6/2009
 
Anticoagulation after mitral surgery: guidelines and practice.
Heart to Heart Module# 17; Paris/France 4/2009
 
Risks and benefits of biological mitral valve replacement.
Edwards Life Science Training Center Nyon/Switzerland 11/2009
 
Mechanical versus biological valve replacement- what are the real risks?
Hospital Gregorio Maranon, Madrid/Spain 9/2009
 
Mechanical versus biological valve replacement- what are the real risks?
Hospital La Fe, Valencia/Spain 9/2009
 
Tricuspid valve regurgitation
Edwards Life Science Training Center Horw/Switzerland 9/2008
 
Mitral Valve replacement: indications and patient profiles
Heart to Heart Module# 15; Paris/France 11/2008
 
Myocardial protection in the failing heart
Verona/Italy PhD lecture 6/2008
 
Gefäßbiologie der Aortenwand
Österreichische Kardiologische Gesellschaft 6/2008
 
Zelltherapie am Herz
Kremser Zelltherapiegespräch 10/2008
 
Myocardial protection in the failing heart
5. Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Herz-, Thorax-, und Gefäßchirurgie
Innsbruck 2.2008
 
Off-pump versus on-pump CABG in patients with poor ejection fraction
Mediterr. Society of Cardiology and Cardiac Surgery; Opatija, 10.2007
 
NO-homeostasis in intraoperative myocardial protection
Harvard Medical School, Dept. of Internal Medicine, Brigham and Women’s Hospital,USA; 7/2007
 
Sex-specific differences in post-MI remodeling
World Congress of Gender Medicine; Wien, 6.2007
 
Gene expression profiling, characterizing the progression of heart failure
2nd Basic Science meeting, University of Verona/Italy, 3.2007
 
Optimizing myocardial protection in the failing heart
2nd Joint Meeting of the Austrian, German and Swiss Societies of Cardiothoracic Surgery and Cardiology; Weissensee, 18.-21.1.2007
 
S-NO-HSA in the treatment of endotheial dysfunction
Jagiellonian Medical Research College, Krakau/Poland 6.2006
 
Neue Wege in der Diagnostik und Prognostik des Herzens
30. Seminar der Österr. Gesellschaft für Chirurg. Forschung 11.2006
 
Endoscopic surgery is realty in today’s cardiac surgery
Europ. Society of Cardiothoracic Surgery, Stockholm/Sweden;9.2006
 
Gene Therapy in CV Research
1st Basic Science meeting, University of Verona/Italy, 6.2006
 
Gene expression profiling, characterizing the progression of heart failure
Universität Göttingen, Abteilung für Innere Medizin und Herzchirurgie Göttingen/Germany, 5.2005
 
Endothelprotektion mit NO-Donatoren
1st Joint Meeting of the Austrian, German and Swiss Societies of Cardiothoracic Surgery and Cardiology
Weissensee, 17.-20.1.2006
 
Molecular profiling: neue diagnostische und prognostische Möglichkeiten in der Herzinsuffizienz;
Jahrestagung der ÖGK, Salzburg 5.2005
 
Endoscopic vein harvesting- another tool in minimal invasisve coronary bypass grafting; Reunion de nuevas technologies, Dept. de Cirurgia Cardiaca,
Malaga/Spain 4.2005
 
Tiermodelle in der CV Forschung
Institut für pharmazeutische Chemie, MUG, Graz 12.2005
 
Pharmacological preconditiong of the transplanted heart.
Annual Meeting of the Polish Society of Pharmacologists, Poznan/Poland 9/2005
 
Gene Therapy in Cardiovascular Research.
EACTS Leipzig/Germany 9. 2004
 
Optimizing ischemia-reperfusion in the failing rat heart- improved myocardial protection with acute ACE-inhibition.
Chirurgenkongress 6. 2004; Billrothpreis
 
Genetic profiling in the scar and remote area of infarction in the failing rat heart.
Cardiac Bioassist Paris/France 12-14 October 2003
 
Reduction of Nuclear factor kappa B activity post myocardial infarction improves ventricular remodeling by attenuating the inflammatory response.
Cardiac Bioassist Paris/France 12-14 October 2003
 
ETA receptor blockade prevents matrix metalloproteinase activation late post- myocardial infarction in the rat.
Rayn Institute of Cardiology, St. Thomas’s Hospital, London/UK 5.6.2001
 
Pharmakologische Interventionen zur Prävention des Ischämie/ Reperfusionsschadens.
Forum Mikrozirkulation; AKH Wien, 23.1.2001
 
Mid-term follow-up of mitral valve reconstruction due to active, infective endocarditis.
World Symposium of Valve Disease, London 11.-14.6.1999
J Heart Valve Dis 2000;9:335-340
 
Techniken minimal-invasiver Koronarchirurgie.
Österreichische Gesellschaft für Chirurgische Forschung, 24. Seminar, Gosau, 15.- 17.11. 2000
 
“Herzliche” Molekularbiologie.
19. Hernsteiner Fortbildungstagung für Intensivmedizin des IZI, Hernstein, 11-13.11.1999
 
Chirurgische Aspekte der ICD Therapie
Frühjahrstagung der Österreichischen Kardiologischen Gesellschaft Gmunden, 1.6.1996
 
Vergleich dreier gängiger Kardioplegielösungen - Untersuchungen am isolierten Herz zur Myokardprotektion während Ischämie und Reperfusion.
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Thorax-, Herz-, und Gefäßchirurgie; Wien 28.2-2.3.1999
 
Ramiprilat during reperfusion.
The Rayn Institute of Cardiology, St. Thomas` Hospital; London/UK 26.4.1995

Last Updated ( Mittwoch, 27 Februar 2013 )